Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05866770 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study Evaluating the Application of Hearing Aid Technologies to Signal Processing for Adult Cochlear Implant Recipients

Study acronym: HATSI-MB
StatusActive, Not Recruiting
PhaseNot applicable
SponsorCochlear
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 22, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 3 of 3 sites
    v6
  2. Minor Start date changed from estimate of Sep 12, 2023 to Sep 11, 2023v5
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date: Jul 31, 2023 to Sep 12, 2023
    • Site details revised at 3 of 3 sites
    v4
  4. Minor Interventions: U8 Research system (Device) to N8 sound processor (Device), U8 (Device)
    • Study arms: 1 to 2
    • Eligibility criteria expanded, about 1 word
    v3
  5. Minor Eligibility criteria shortened, about 5 wordsv2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
28 trials monitored
See all monitored trials
A feasibility, prospective, multi-centre, repeated measures investigation evaluating the application of hearing aid technologies to signal processing for adult cochlear implant recipients
Trial Details
NCT Number NCT05866770
Lead Sponsor Cochlear
Collaborators: Avania
Conditions
(from sponsor)
Hearing Loss
Related terms Hearing Loss
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov